Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : BTL-TML-COVID
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Norwich Clinical Research Associates | Curavit Clinical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 21, 2020
Lead Product(s) : BTL-TML-COVID
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Norwich Clinical Research Associates | Curavit Clinical Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Thimerosal
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Beech Tree Labs is Developing a Potential Antiviral Therapy to Fight COVID-19 Pandemic
Details : Beech Tree Labs sponsored two Phase 2 clinical trials that demonstrated the safety and efficacy of TML to reduce the onset of Herpes virus lesions after exposure to dental procedure or sunlight. The p value of the combined studies was 0.019. No adverse e...
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 04, 2020
Lead Product(s) : Thimerosal
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : BTL-TML-HSV
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Norwich Clinical Research Associates | Hill Top Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 18, 2013
Lead Product(s) : BTL-TML-HSV
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Norwich Clinical Research Associates | Hill Top Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : UISH001
Therapeutic Area : Urology
Study Phase : Phase I/ Phase II
Sponsor : Norwich Clinical Research Associates
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
April 22, 2011
Lead Product(s) : UISH001
Therapeutic Area : Urology
Highest Development Status : Phase I/ Phase II
Sponsor : Norwich Clinical Research Associates
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : BTL-TML-HSV
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I/ Phase II
Sponsor : Norwich Clinical Research Associates
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 04, 2011
Lead Product(s) : BTL-TML-HSV
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I/ Phase II
Sponsor : Norwich Clinical Research Associates
Deal Size : Inapplicable
Deal Type : Inapplicable